MarketsStocksKREBSBIO
KR

Krebs Biochemicals and Industries Limited

NSE: KREBSBIO BSE: 524518Healthcare
Download Research Report7-page PDF
65.23
+2.76%
NSE · auto-updates while market open
Prev Close
₹90.01
Day High
₹67.89
Day Low
₹64.01
Mkt Cap
₹141 Cr
P / E
-
P / B
-
ROE
-
52W High
₹104.00
52W Low
₹38.33
Delivery
88% · avg 74%
Key Metrics
Market Cap
₹141 Cr
P / E
-
P / B
-
EV / EBITDA
-
ROCE
-
ROE
-
Debt / Equity
-
Book Value
-
EPS
-
Div Yield
0.0%
Face Value
₹10
Promoter Holding
72.7%
P / E Ratio · price ÷ TTM EPS
1-40-8Apr 26Apr 26May 26Jun 26
TTM EPS
Q4 '26 snapshot
Sales
₹9 Cr
Operating profit
-
OPM
-
Net profit
₹-2 Cr
EPS
-
Scorecard · 7 axes
Quality
Strong
100/100
Valuation
-
Growth
-
Profitability
-
Performance
Bad
-26.7%
Entry Point
Good
63%
Red Flags
Strong
0 flags
Shareholding Pattern
72.7%Promoter
Promoter72.7%
Public27.3%
Quarterly Results · ₹ Cr
QuarterQ1 '26Q2 '26Q3 '26Q4 '26
Revenue5.494.177.288.81
Net Profit-5.324-6.143-3.126-2.34
NPM %-97.0%-147.3%-42.9%-26.6%
AlertPre-trade